NCT06572111View on ClinicalTrials.gov

A Study in Healthy Men to Test How BI 1839100 is Taken up and Handled by the Body

PHASE1TerminatedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

September 30, 2024

Primary Completion Date

October 28, 2024

Study Completion Date

September 2, 2025

Conditions
Healthy
Interventions
DRUG

BI 1839100 (C-14) formulation 1

BI 1839100 (C-14) formulation 1

DRUG

BI 1839100

BI 1839100

DRUG

BI 1839100 (C-14) formulation 2

BI 1839100 (C-14) formulation 2

Trial Locations (1)

9728 NZ

ICON-Groningen-62040, Groningen

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT06572111 - A Study in Healthy Men to Test How BI 1839100 is Taken up and Handled by the Body | Biotech Hunter | Biotech Hunter